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Sir William Dunn School of Pathology, University of Oxford, Oxford, UK
The gastrointestinal tract presents a unique challenge to the mucosal immune system, 
which has to constantly monitor the vast surface for the presence of pathogens, while at 
the same time maintaining tolerance to beneficial or innocuous antigens. In the intestinal 
mucosa, specialized innate and adaptive immune components participate in directing 
appropriate immune responses toward these diverse challenges. Recent studies provide 
compelling evidence that the process of autophagy influences several aspects of muco-
sal immune responses. Initially described as a “self-eating” survival pathway that enables 
nutrient recycling during starvation, autophagy has now been connected to multiple 
cellular responses, including several aspects of immunity. Initial links between autophagy 
and host immunity came from the observations that autophagy can target intracellular 
bacteria for degradation. However, subsequent studies indicated that autophagy plays 
a much broader role in immune responses, as it can impact antigen processing, thymic 
selection, lymphocyte homeostasis, and the regulation of immunoglobulin and cytokine 
secretion. In this review, we provide a comprehensive overview of mucosal immune cells 
and discuss how autophagy influences many aspects of their physiology and function. 
We focus on cell type-specific roles of autophagy in the gut, with a particular emphasis 
on the effects of autophagy on the intestinal T cell compartment. We also provide a 
perspective on how manipulation of autophagy may potentially be used to treat mucosal 
inflammatory disorders.
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iNTRODUCTiON
The gastrointestinal tract contains a vast network of non-lymphoid and secondary lymphoid tissues 
that host numerous populations of leukocytes, many of which are intestine-specific subpopula-
tions (1). The gut-associated lymphoid tissue (GALT) comprises the immune cells residing in 
the intestinal epithelium and lamina propria (LP) compartments, as well as various secondary 
lymphoid structures, including the mesenteric lymph nodes (mLNs), the Peyer’s patches (PP) of the 
small intestine, and isolated lymphoid follicles and cryptopatches that are distributed throughout 
the intestine (2). The intestinal mucosa, comprising the epithelium, the underlying LP, and the 
muscularis mucosa, is the site where majority of immunological processes occur (Figure 1).
The immune system has evolved to prevent invasion of the host by microbial species. However, 
the mammalian gastrointestinal tract is a preferential site for colonization of the host by commensals, 
a diverse community consisting of fungal, viral, and bacterial species. The presence of a commensal 
microbiota is vital for optimal digestion and nutrient acquisition, as well as resistance to pathogenic 
infection, but commensal microbes also contribute to the development, maturation, and  activation of 
the host immune system by influencing both innate and adaptive immune responses (3). A mutualistic 
FiGURe 1 | The colonic mucosa. The epithelial cell layer of the intestinal mucosa separates the luminal content harboring the microflora (green) from the 
underlying lamina propria. Specialized secretory epithelial cells, termed goblet cells, produce and secrete mucus to enforce the barrier (red). Cell nuclei are stained 
in blue.
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dialog between the microbiota and intestinal immune system 
maintains peaceful coexistence, through multiple mechanisms 
that we are just beginning to understand (3, 4). Besides microbial 
communities, the intestinal immune system constantly encoun-
ters a vast dietary antigenic load, and the induction of a state of 
immune unresponsiveness toward these antigens (oral tolerance) 
is key function of the mucosal immune system (5). Therefore, 
the intestinal immune system often employs different rules than 
the systemic immune system to ensure the right balance between 
tolerance and immunity is maintained. Disruption of this equi-
librium can lead to the chronic immune-mediated pathologies 
of the gastrointestinal tract, such as inflammatory bowel disease 
(IBD) or food allergies (5, 6).
The term IBD describes a spectrum of chronic incurable 
inflammatory disorders affecting the gastrointestinal tract, but 
often with extra-intestinal manifestations, with the two most 
common forms being Crohn’s disease (CD) and ulcerative colitis 
(UC) (7). IBD is a complex multifactorial disease that emerges 
on a background of many genetic and environmental factors 
(6). In recent years, there has been a tremendous progress in 
understanding the genetics of IBD susceptibility, facilitated 
by technological progress that led to large-scale genome-wide 
association studies (GWAS), followed by meta-analysis and 
targeted genotype arrays (Immunochip) (8). Currently, 163 loci 
associated with IBD have been identified, which are far more 
than any other complex immunological disease to date (9). A 
considerable proportion of IBD-associated genes are involved in 
immune cell function, innate and adaptive immune responses, 
promotion of epithelial barrier integrity and bacterial handling 
(9). Among these, a single-nucleotide polymorphism (SNP) in 
ATG16L1 was identified as a strongly associated risk locus for 
CD, suggesting for the first time a role for the macroautophagy 
(herein referred to as autophagy) pathway in IBD (10, 11). 
Importantly, it was recently shown that homozygous expres-
sion of the CD susceptibility variant T300A allele of ATG16L1 
results in defective autophagy during stress conditions (12, 
13). Additionally, SNPs in several other autophagy-associated 
genes, including IRGM, LRRK2, SMURF1, and NDP52, have 
been linked to IBD susceptibility (9), strongly suggesting that 
it is the classical autophagy pathway that connects these genetic 
alterations to impaired intestinal homeostasis. However, the 
identification of susceptibility polymorphisms provides only 
correlative evidence for the involvement of specific genes or 
pathways, and an understanding of the functional consequences 
of the majority of genetic polymorphisms is still lacking. In the 
case of autophagy, however, we are beginning to understand how 
modulation of this pathway affects various aspects of mucosal 
immune cell physiology.
THe AUTOPHAGY PATHwAY
Degradation and recycling of cellular components is critical for 
all eukaryotic cells in order to maintain cellular homeostasis. 
The autophagy pathway degrades large cytoplasmic components, 
including organelles, long-lived proteins, and protein aggre-
gates, as well as intracellular pathogens, by sequestering these 
constituents in double-membrane vesicles and delivering this 
cargo for lysosomal degradation (14). Autophagy is an evolu-
tionary conserved process occurring throughout the eukaryotic 
phylogenetic tree, with the core autophagy machinery proteins 
showing great homology between yeast and mammalian cells 
(15, 16), and its essential physiological role is indicated by the 
observation that mice lacking essential autophagy genes are 
unable to survive the neonatal starvation period and die shortly 
after birth (17).
During autophagy, sequestration of the cytosolic cargo 
involves “de novo” formation of an isolation membrane that sur-
rounds the cytosolic material to be degraded, forming an inter-
mediate vesicle called an autophagosome. The autophagosome 
subsequently fuses with the lysosome leading to the formation 
of the digestive compartment  –  the autolysosome. Lysosomal 
enzymes degrade the content of the vesicle, which facilitates the 
permease-mediated release of the recycled molecules via the 
lysosomal membrane (16, 18, 19) (Figure 2). While autophagy 
is the primary cell response to the stress of nutrient deprivation, 
in recent years, more complex and cell type-specific functions 
have emerged, including roles in innate and adaptive immune 
responses (20, 21).
Although originally described as a non-selective pathway for 
bulk degradation, autophagy can also act as a highly selective 
FiGURe 2 | The autophagy pathway. Autophagosome formation is a stepwise process characterized by dynamic remodeling of cytoplasmic membranes. 
Proteins that control activation, elongation, and completion of an autophagosome are grouped into five functional complexes that are active at different stages of the 
autophagy pathway.
3
Kabat et al. Autophagy in Mucosal Immunity
Frontiers in Immunology | www.frontiersin.org June 2016 | Volume 7 | Article 240
4Kabat et al. Autophagy in Mucosal Immunity
Frontiers in Immunology | www.frontiersin.org June 2016 | Volume 7 | Article 240
process. While metabolic stress mainly triggers non-selective 
autophagy where a portion of the cytoplasm is targeted for 
degradation, intracellular pathogens or damaged organelles are 
targeted in a selective fashion. This is achieved by the use of cargo-
specific autophagy adaptors. These adaptors are able to recognize 
ubiquitinated substrates and target them to the autophagosome, 
a process that also requires adaptor binding to the protein LC3 
(microtubule-associated protein L chain 3) or γ-aminobutyric 
acid receptor-associated proteins (GABARAP), through a spe-
cific amino acid sequence called the LC3-interacting region (LIR) 
(22, 23). To date, there is evidence for the targeted sequestration 
and selective autophagy of a diverse array of cytosolic cargos, 
including aggregate-prone or misfolded proteins (aggrephagy) 
(22, 24–26), protein complexes in signaling cascades (27–29), 
peroxisomes (pexophagy) (30, 31), mitochondria (mitophagy) 
(32–38), surplus ER (reticulophagy) (39, 40), ribosomes (ribo-
phagy) (40, 41), ferritin (ferritinophagy) (42, 43), bacteria and 
viruses (xenophagy) (21), lipid droplets (lipophagy) (44), and 
glycogen (glycophagy) (45, 46). The diversity of autophagy targets 
highlights the complex role of this pathway in regulating many 
aspects of cellular physiology during steady-state and in stress 
responses.
Molecular Mechanisms of Autophagy
Formation of the double-membrane autophagosome structure is 
the key step in autophagy. There are nearly 40 autophagy-related 
(Atg) proteins that facilitate crucial steps of autophagosome 
formation and degradation (47). Autophagy is initiated by the 
formation of the isolation membrane, also called a phagophore, 
at the phagophore assembly site (PAS). The core autophagy 
machinery in mammalian cells can be categorized into five 
functional groups (Figure  2). The primary initiation complex, 
comprising unc-51-like kinase-1 or 2 (Ulk1/2) – Atg13 – FIP200 
– Atg101, is reciprocally controlled by mechanistic target of rapa-
mycin complex 1 (mTORC1) and AMP-activated protein kinase 
(AMPK). Activated Ulk1/2 complex translocates to the site of 
autophagosome formation and activates the second functional 
complex, the class III phosphatidylinositol 3-kinase (PI3K) 
complex, whose main components are vacuolar protein sorting 
34 (Vps34), Beclin1, autophagy/beclin-1 regulator 1 (AMBRA1), 
and Atg14 (48–51). The PI3K complex mediates the nucleation 
step of phagophore formation. Once activated, this complex 
produces phosphatidylinositol-3-phosphate (PI3P) leading to 
recruitment of PI3P-binding effector proteins to the phagophore 
membrane, including WD-repeat domain phosphatidylinositide-
interacting-1 or -2 (WIPI1/2) (52–54). The third complex 
consists of Atg9, the only known transmembrane Atg protein, 
and its cycling system, involving Atg2 and WIPI1/2, that shuttle 
among endosomes, autophagosomes, and the Golgi apparatus. 
Atg9-positive vesicles are thought to provide membrane for the 
growing autophagosome (55, 56). Once initiated, elongation of 
the isolation membrane requires the subsequent action of two 
ubiquitin-like (UBL) conjugation systems: the Atg5–Atg12/
Atg16l1 complex, which is assembled through the action of Atg7 
(E1-like enzyme) and Atg10 (E2-like enzyme) and then locates 
to the growing autophagosome membrane (57–61); and the LC3 
complex, containing LC3A/B/C, GABARAP, GABARAPL1/2, 
Atg7, Atg3 (E2-like enzyme), and the cysteine protease Atg4, 
which cleaves LC3 at the C-terminus to expose glycine, allow-
ing the conjugation of the membrane lipid phosphatidyletha-
nolamine (PE) to the soluble form of LC3, named LC3-I, and 
subsequent incorporation of LC3-PE (also called LC3-II) into 
the inner and outer membranes of autophagosomes (57, 62–64). 
The Atg5–Atg12/Atg16l1 complex acts as an E3-like enzyme 
during LC3 lipidation (58, 65). LC3-II that is bound to the isola-
tion membrane is thought to play not only a scaffolding role in 
membrane growth and is needed for autophagosome closure 
but is also important for the binding of autophagy adaptors 
and thus in mediating selective types of autophagy (66). The 
mature autophagosome migrates into close proximity to the 
lysosome through the action of the dynein motor complex and 
microtubules (67). Fusion with the lysosome requires the action 
of the HOPS complex (homotypic fusion and protein sorting) 
and SNARE proteins (soluble NSF attachment protein receptors) 
(68–71). Upon formation of the autolysosome compartment, 
lysosomal acidic hydrolases degrade the inner membrane and 
the luminal content. Ultimately, this provides building blocks for 
anabolic processes and fuel for ATP synthesis. Eventually, the 
autolysosome fissions to release lysosomes and autophagy are 
terminated (72).
Cytoplasmic and Nuclear Regulation 
of Autophagy
Autophagy is modulated in response to adverse micronenvi-
ronmental conditions, including nutrient depletion, hypoxia, 
growth factor withdrawal, inflammatory cytokines, and infec-
tion. As such, a network of regulatory pathways governs its 
activity. For a long time, autophagy was believed to be predomi-
nantly regulated at the post-transcriptional level by signaling 
mediators. Recently, however, mechanisms of transcriptional, 
translational, and epigenetic regulation of the autophagy path-
way have emerged. It is now thought that cytosolic regulation 
generally serves as a more rapid, short-term response, whereas 
transcriptional modulation provides long-term regulation, 
although some nuclear events can also have a rapid effect on 
autophagy (72–74).
The primary role of autophagy is to respond to cellular 
metabolic perturbations. Many signals that modulate autophagy 
levels do so by converging on the mechanistic target of rapamycin 
complex 1 (mTORC1). mTOR is a conserved serine/threonine 
kinase that integrates signals from various stimuli, includ-
ing amino acids, growth factors, energy, glucose, and oxygen 
levels (75). The autophagy pathway is regulated by mTORC1 
in several ways. In the presence of nutrients, including amino 
acids, mTORC1 is active and suppresses autophagy through 
inhibitory phosphorylation of Ulk1, Atg13, AMBRA, and 
Atg14 (51, 76–80). During starvation, mTORC1 is inhibited, 
which activates autophagy. Autophagy activity eventually leads 
to increased nutrient levels, which in turn reactivates mTORC1 
to terminate autophagy. This reactivation of mTORC1 that 
occurs during prolonged starvation is critical for the restora-
tion of lysosomal homeostasis after prolonged autophagy (81). 
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Another key sensor that coordinates cellular metabolic responses 
is AMPK, which, next to mTOR, can be considered a signaling 
hub for autophagy modulation. AMPK is a serine/threonine 
kinase that senses decreased energy levels by detecting changes 
in the ATP:ADP:AMP ratio in the cytoplasm (82). In response 
to decreased intracellular ATP levels, AMPK initiates metabolic 
reprograming toward catabolic reactions, including stimulation 
of autophagy through direct phosphorylation of the Ulk1/2 (76, 
83, 84). AMPK can also phosphorylate various components of 
the Vps34 complexes that do not contain proautophagic adap-
tors, leading to the inhibition of its non-autophagic functions in 
Golgi–endosome trafficking (85). In addition to direct interac-
tions, AMPK can indirectly activate autophagy by inhibiting 
mTORC1 (86, 87). Importantly though, AMPK activity is not 
indispensable for autophagy induction, as starvation still induces 
autophagy in AMPK-null cells, suggesting a role for this kinase 
in fine-tuning autophagy modulation (76).
Transcriptional regulation is now appreciated to be one of the 
main regulatory mechanisms of autophagy. The transcription fac-
tor EB (TFEB) is a master regulator of lysosomal and autophagy 
gene expression (88). TFEB controls the gene network called 
coordinated lysosomal expression and regulation (CLEAR), 
which contains the majority of genes encoding lysosomal pro-
teins (89). TFEB also regulates the expression of several genes 
encoding proteins belonging to the core autophagy machinery, 
including Lc3, p62, and Atg9 (73, 88). Upon autophagy induction, 
TFEB is rapidly recruited from the cytosol to the nucleus, and this 
is at least partially mediated by inhibition of mTORC1. Active 
mTORC1 mediates the phosphorylation of TFEB, which results 
in its sequestration in the cytoplasm (90–92). Acting in opposi-
tion to TFEB, the DNA-binding protein zinc-finger protein with 
KRAB and SCAN domains 3 (ZKSCAN3) represses an extensive 
set of autophagy genes, including Lc3 and WIPI2 (93). During 
starvation, ZKSCAN3 accumulates in the cytoplasm, and its 
activity is inhibited. Thus, TFEB and ZKSCAN3 seem to provide 
a switch mechanism during starvation-induced autophagy (73). 
In summary, multiple intersecting pathways modulate autophagy 
on many levels, reflecting the importance of this complex 
homeostatic pathway in the cellular adaptations to environmental 
factors.
AUTOPHAGY HAS DiveRSe ROLeS iN 
CeLLS OF THe iNTeSTiNAL MUCOSA
intestinal epithelial Cells in Barrier 
Function and immune Homeostasis
Intestinal epithelial cells (IECs) form a single cell layer 
separating the intestinal mucosa from the lumen. The primary 
function of these cells is nutrient absorption from the lumen; 
however, their interactions with the intestinal microbiota and 
host leukocytes strongly influence immune responses (94). The 
IEC monolayer is composed of several specialized cell types: 
stem cells, Paneth cells, goblet cells, neuroendocrine cells, and 
enteroabsorptive cells (95). Multipotent Lgr5+ stem cells are 
located at the bottom of the intestinal crypts and by division 
these cells give rise to either transient amplifying cells or stem 
cells. The transient amplifying cells rapidly proliferate and 
differentiate and thereby ensure the renewal of the epithelial 
layer every 4–5 days (95). Paneth cells that localize to the base 
of small intestinal crypts are specialized secretory cells that 
produce large amounts of antimicrobial molecules, including 
lysozyme, α-defensins, and Reg3γ (Reg3α in humans) (96). 
Antimicrobial peptides (AMP) play a crucial role not only in 
the defense against enteric pathogens but also in shaping the 
host microbiota, as mice lacking MMP7, an enzyme required 
for the maturation of α-defensins, exhibited significant changes 
in the microbiota composition (97). In addition, AMP have 
modulatory functions in chemotaxis, toll-like receptors (TLR) 
signaling, and wound healing (98). Paneth cells also participate 
in maintaining crypt stem cell activity through production of 
EGF, TGF-α, Wnt3, and the Notch ligand Dll4 (99). Goblet 
cells are another class of secretory cells that produce heavily 
glycosylated mucins which, after secretion to the lumen, form 
a mucus gel layer (94). This serves as a protective physical 
barrier and as a matrix loaded with secretory IgA (sIgA) and 
AMP, which fortify the mucosal barrier (4). Recent studies 
have suggested that mucus also has an additional role in 
promoting tolerogenic responses toward food and commensal 
antigens (100, 101). The observation that mice with defects 
in MUC2 production develop spontaneous colitis emphasizes 
that mucus is essential for intestinal homeostasis (102, 103). 
IECs are actively engaged in the dialog between the microbiota 
and the immune system. Sensing of bacterial metabolites and 
structural components by IECs fortifies barrier integrity and 
protects from pathogen invasion (104). For example, recent 
studies underlined the crucial role of inflammasome signaling 
in the epithelium in regulating microbiota composition and for 
protection against infectious colitis (105–107). In addition, the 
metabolite acetate, produced by commensal bacteria belonging 
to the genus Bifidobacterium, protected against mortality dur-
ing enterohemorrhagic Escherichia coli infection by promoting 
anti-apoptotic responses in IECs (108). IECs also influence the 
recruitment, activation and differentiation of leukocytes by 
producing various other modulatory factors in response to com-
mensal microbiota, including thymic stromal lymphopoietin 
(TSLP), TGF-β1, RA, IL-25, and IL-18 (4, 109).
Autophagy Reinforces Barrier and 
Secretory Functions of ieCs
The IEC monolayer is in close proximity to microbiota com-
munities within the gastrointestinal tract and is an entry site 
for mucosal pathogens. Recent studies that assessed the impact 
of autophagy deficiency on bacterial handling by IECs found 
that autophagy was essential for protection against intracellular 
bacteria, including Salmonella typhimurium and Shigella flexneri, 
by acting to limit bacterial replication and subsequent dissemi-
nation to other tissues (13, 110–112) (Figure 3). Furthermore, 
a recent study showed that autophagy induction reduced tight 
junction permeability in IECs by targeting the pore forming pro-
tein claudin-2 for degradation (113), highlighting an additional 
FiGURe 3 | Cell-specific functions of autophagy in the intestinal mucosa. Autophagy pathway is essential for several key functions of distinct cell types that 
promote intestinal immune homeostasis. Perturbation in the autophagy pathway results in decreased antibacterial defense in IECs and MPs. Autophagy also 
facilitates secretory functions of Paneth cells and goblet cells, is involved in antigen presentation by DC, and limits proinflammatory cytokine production from MP. 
Furthermore, defects in autophagy pathway strongly compromise the survival of particular subsets of T cells and B cells.
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mechanism through which autophagy may enhance barrier 
function.
Many studies of autophagy in IECs have concentrated on the 
functional role of ATG16L1, and in trying to understand how 
CD-associated polymorphisms in ATG16L1 may impact on epi-
thelial homeostasis. It has been reported that Paneth cells from 
patients with CD homozygous for the ATG16L1 T300A variant 
allele, or from mice with a hypomorphic mutation of Atg16l1, 
exhibit abnormal granule structure and reduced AMP secretion 
(114, 115) (Figure  3). However, Atg16l1 hypomorphic mice 
did not exhibit signs of spontaneous intestinal inflammation, 
although they showed increased susceptibility to DSS-induced 
colitis. This increased susceptibility of Atg16l1 hypomorphic 
mice, as well as their Paneth cell abnormalities, was only 
observed when the mice harbored a commensal microbiota that 
contained a persistent enteric norovirus (MNV) (114, 115). These 
studies suggested that decreased autophagy levels drive Paneth 
cell abnormalities only when additional triggering factors are 
present. A recent study showed that ER stress could also be such 
a trigger (116). Analyses of mice with an IEC-specific deletion 
of the unfolded protein response (UPR) response element Xbp1 
demonstrated that defects in the UPR pathway in Paneth cells 
were partially compensated by increased autophagy. However, 
when autophagy was also impaired, through IEC-specific dele-
tion of Atg16l1 or Atg7, ER stress could not be resolved and 
this double defect led to the development of severe intestinal 
inflammation (116). Interestingly, Paneth cells from patients 
with the ATG16L1 T300A variant allele showed increased ER 
stress markers (117).
Consistent with the notion that manifestation of defec-
tive autophagy in Paneth cells could depend on additional 
environmental or genetic factors, two recent studies reported 
contradictory results when mice with a “knock-in” of the risk-
associated Atg16l1 gene variant (T316A) were analyzed. Murthy 
et al. reported no changes in the morphology of Paneth cells in the 
knock-in mice (12), whereas Lassen et al. observed spontaneous 
Paneth cell abnormalities (13). One possible explanation for these 
differences could be the distinct microbiota composition of mice 
housed in different facilities. Beyond Paneth cells, autophagy 
could also play an important functional role in other secretory 
IEC types, as Atg5-deficient colonic goblet cells were also reported 
to show impaired granule formation (118). Taken together, 
these studies indicate that autophagy plays an important role 
in fortifying intestinal epithelial barrier function by enhancing 
resistance to intracellular bacteria and by regulating the functions 
of secretory IECs (Figure 3).
Mononuclear Phagocytes Regulate 
intestinal immune Homeostasis
Mucosal mononuclear phagocytes (MPs) comprise dendritic 
cells (DCs) and macrophages. These cells are key players in 
intestinal homeostasis, as they provide a crucial link between 
innate and adaptive immunity, and in maintaining functional 
compartmentalization of the systemic and mucosal immune 
system. Intestinal MPs are a heterogeneous population; expres-
sion of CX3C chemokine receptor 1 (CX3CR1) and CD103 
(αE integrin) can be used to identify two major intestinal MP 
populations, which appear to promote intestinal tolerance in dif-
ferent ways (119, 120). Under homeostatic conditions, CD103+ 
DCs acquire intestinal antigens and migrate from the intestinal 
LP to the mLNs, where they initiate T cell responses, promoting 
intestinal tropism through induction of homing receptors CCR9 
and α4β7, and preferentially inducing tolerogenic Treg cells 
7Kabat et al. Autophagy in Mucosal Immunity
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through production of TGF-β1 and RA (121–123). The ability 
to convert latent TGF-β1 into its active form is important for 
this tolerogenic CD103+ DC function (124, 125). Additionally, 
this CD103+ DC subset also acts on B cells, promoting dif-
ferentiation of naive B cells into IgA+ plasma cells within the 
intestinal LP (126). CD103+ DCs have also been identified as a 
crucial subset in promoting oral tolerance against food antigens 
(5), although CX3CR1+ MPs may augment Treg cell induction 
by CD103+ DCs through the transfer of soluble food antigens 
via gap junctions (127). CX3CR1+ MPs (a population comprising 
both DCs and macrophages) sample luminal contents through 
extended dendrites but appear to be non-migratory and have 
poor abilities for naive T cell priming (128–130). However, 
CX3CR1+ MPs may be involved in the secondary expansion of 
Tregs in the LP that had been primed initially in gut-draining 
lymph nodes (131).
During infection or inflammation, intestinal MPs adopt a 
different phenotype, characterized by the production of pro-
inflammatory cytokines and chemokines that coordinate host 
protective immune responses, but excessive activation of mucosal 
myeloid cells has also been associated with chronic inflammatory 
conditions (132–134). Commensal bacteria are able to directly 
modulate intestinal MP functions to regulate effector T cell 
responses in the LP. For instance, Atarashi et  al. showed that 
ATP produced by commensal bacteria activates CX3CR1+ MPs 
and leads to the induction of Th17 cells (135), and microbiota-
derived signals were shown to induce IL-1β production from 
mucosal MPs that is essential for the induction of Th17 cells in 
the steady-state gut (136).
Autophagy Regulates Proinflammatory 
Signaling in Mononuclear Phagocytes
Antigen presentation by intestinal MP is crucial in orchestrating 
protective and tolerogenic responses in the mucosa. The role of 
autophagy in major histocompatibility complex class II (MHC II) 
antigen presentation is well documented; autophagy can enhance 
MHC II expression on MPs and is directly engaged in deliver-
ing cytoplasmic antigens, including bacterial and viral antigens, 
into MHC II compartments (137–140) (Figure 3). There is also 
evidence that autophagy may contribute to processing of viral 
antigens for MHC I presentation (141, 142).
As professional phagocytic cells, DCs and macrophages are 
particularly well equipped to handle bacteria, and autophagy 
is now appreciated to play an important role in intracellular 
bacterial killing (Figure 3). Autophagy can be activated in MPs 
by pattern recognition receptor (PRR) triggering, including 
activation of TLR (143–147) or NOD-like receptors (NLR) (112, 
148). In particular, activation of DCs and macrophages with the 
NOD2 ligand muramyl di-peptide (MDP) induces autophagy 
and thereby enhanced bacterial killing, and this activation is 
reduced in DCs with the ATG16L1 T300A allele variant (112, 
148). Activation of NOD1 and NOD2 in the cytoplasm directs 
the autophagy machinery by recruiting ATG16L1 to the site 
of bacterial entry, although this interaction was not affected 
in cells with homozygous expression of the T300A variant 
(112). Of note, autophagy induction downstream of PRRs is 
not limited to myeloid cells, as autophagy is also activated in 
epithelial cells in response to NOD1 and NOD2 triggering (112), 
and bacterial outer membrane vesicles (OMV) were shown to 
selectively activate NOD1-dependent autophagy in an epithelial 
cell line (149).
Sequestration of cytosolic bacteria by xenophagy requires 
the coordinated action of specialized autophagy adaptors that 
recognize ubiquitin-tagged or galectin-tagged pathogens for 
degradation (150). The importance of autophagy in defense 
against cytosolic pathogens is highlighted by the fact that several 
pathogens have developed sophisticated adaptations to inhibit 
specific stages of autophagy (21, 151) and others even hijack 
the pathway for their own propagation (152). An essential role 
for autophagy in intestinal pathogen handling in DCs and mac-
rophages has been observed in Salmonella, Shigella, and Listeria 
infections (153, 154).
In addition to PRR triggering, inflammatory cytokines can 
also influence autophagy in MPs. For instance, autophagy is 
induced by IFN-γ and other Th1 type cytokines that are secreted 
during bacterial infection, while Th2 type cytokines inhibit 
autophagy (21). Conversely, autophagy can also influence 
cytokine signaling in myeloid cells. In particular, autophagy 
was shown to downregulate secretion of the inflammasome-
associated cytokines IL-1β and IL-18 by murine and human 
macrophages (155–157) (Figure 3). In addition, IL-1β produced 
by activated autophagy-deficient macrophages can enhance 
their secretion of IL-23, thereby further potentiating inflam-
matory responses (157). The link between autophagy defects 
and excessive inflammasome activation was related to reactive 
oxygen species (ROS) production in response to mitochondrial 
stress (158–160), as well as defects in targeting of assembled 
inflammasomes, or components of the inflammasome pathway, 
for autophagosomal degradation (27, 161) (Figure 4). Recently, 
NFκB signaling was linked to autophagy-mediated silencing 
of inflammasomes in macrophages, as NFκB promoted the 
expression of the adaptor p62 that was needed for the removal 
of damaged mitochondria (162). In the absence of p62, signals 
from damaged mitochondria enhanced NLRP3 inflammasome 
activation (162). Consistent with these findings that autophagy 
functions as a key regulator of inflammasomes, in bone marrow 
chimeric mice with an Atg16l1-deficient hematopoietic com-
partment, increased production of inflammasome-dependent 
cytokines was associated with increased susceptibility to DSS-
induced colitis (155). Furthermore, a recent study suggested 
that protective autophagy in MPs might be triggered through 
the activation of GCN2, a nutrient deprivation sensor kinase 
that was previously shown to facilitate antigen presentation by 
DCs through autophagy induction (163, 164). GCN2 promoted 
autophagy in intestinal MP during amino acid starvation or 
acute inflammation and this acted to limit ROS production and 
consequent inflammasome activation and thus had a protective 
effect on DSS colitis (164).
Although autophagy appears to negatively regulate inflam-
masome pathway at several stages, there is some evidence that, 
conversely, it might contribute to the secretion of IL-1β and 
IL-18 under some circumstances (165–167). IL-1β and IL-18 do 
not contain signal peptide and thus cannot access the classical 
FiGURe 4 | Autophagy regulates inflammasome-associated cytokine responses. Autophagy negatively regulates production of proinflammatory IL-1β in 
MPs through several mechanisms, indirectly through degradation of damaged mitochondria (mitophagy) to limit ROS production, and directly through degradation of 
inflammasome complexes and pro-IL-1β. Autophagy may also positively regulate IL-1β by mediating its unconventional extracellular secretion.
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secretory pathway; however, the mechanism of their uncon-
ventional secretion remains debatable. For instance, starvation-
induced autophagy leads to increased IL-1β and IL-18 secretion 
in macrophages following inflammasome triggering, and this 
response was partially autophagy dependent (165). More recently, 
Zhang et al. proposed that autophagy-mediated secretion of IL-1β 
is mediated through sequestration of a fraction of this cytokine in 
the space between the membranes of the autophagosome, where 
it is protected from degradation (167).
Overall, these studies indicate that autophagy can both 
negatively and positively regulate inflammasome signaling 
(Figure 4) and suggest that this may depend on the timing and 
context of autophagy and inflammasome induction. It will now 
be important to fully understand what immunological clues 
dictate the location, and thus the fate of IL-1β and IL-18 within 
autophagosomes, and to investigate whether the tissue location 
of the MPs has an influence on how autophagy regulates inflam-
masome signaling.
Besides the crosstalk between autophagy and inflammasome 
signaling, autophagy also regulates type I IFN responses. In 
plasmacytoid DCs, autophagy was essential for IFN-α produc-
tion in response to viral dsRNA, and this was attributed to the 
role of autophagy in delivering viral replication intermediates 
to endosomal TLR7 (147). Conversely, in some instances, 
autophagy appears to negatively regulate virus-sensing pathways 
by limiting signaling through RIG-1-like receptors (RLR) (168, 
169). Additionally, autophagy was shown to enhance NFκB 
signaling in F4/80hi macrophages by selective degradation of the 
negative regulator A20 and this contributed to enhanced protec-
tion against Candida albicans infection (170). This is interesting, 
as autophagy was previously shown to limit NFκB signaling in 
intestinal epithelial cells (171) and activated T cells through 
selective degradation of Bcl-10 (29), suggesting that the impact 
of autophagy on NFκB activation could be cell type specific or 
context dependent. Additionally, it was recently demonstrated 
that autophagy-deficient macrophages show increased secretion 
of macrophage migration inhibitory factor (MIF) (172), a pleio-
tropic proinflammatory cytokine implicated in the pathology 
of IBD (173, 174), and that this increase was dependent on the 
mitochondrial ROS (172). Taken together, these studies indicate 
that the autophagy pathway intersects with other pathogen sens-
ing and cellular stress responses to promote immune defense 
in MP populations. However, detailed analysis of the role of 
autophagy in the intestinal subsets of DCs and macrophages is 
lacking. Since mucosal MPs show some unique features, includ-
ing hyporesponsiveness to PRR stimulation (134), it will be 
important to investigate the potential contribution of autophagy 
to these specific intestinal adaptations.
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Antibody Production and Secretion  
in the intestine
B cells are abundant within the GALT. Intestinal B cell develop-
ment shows some unique features as LP-resident B cells appear to 
undergo V(D)J recombination and B cell receptor (BCR) editing 
(175). Early B cell development in the gut was promoted by com-
mensals, suggesting involvement of microbiota-derived antigens 
in driving BCR editing (175), which might have implications for 
immunoglobulin diversification at mucosal sites and for toler-
ance against commensal antigens. Intestinal plasma cells can also 
acquire unique “innate like” properties that are dependent on 
microbiota stimulation, as IgA+ plasma cells can secrete TNFα 
and inducible nitric oxide synthase (iNOS) (176).
It is estimated that around 80% of the total antibody production 
takes place in the intestinal mucosa, making the gut the largest 
antibody-producing organ of the body (177). IgA constitutes the 
major antibody isotype produced and sIgA is the most abundant 
immunoglobulin in mucosal secretions (178). sIgA is a dimeric 
antibody that binds to the polymeric Ig receptor (pIgR) on the 
basolateral surface of IECs and is subsequently translocated 
across the epithelium and released into the lumen, where it 
interacts with various intestinal antigens, including self, dietary, 
and commensal antigens. This limits the access of commensal 
bacteria and soluble antigens to the intestinal epithelium and LP, 
and it appears that bacteria with higher potential to elicit local 
inflammatory responses can be distinguished on the basis of their 
high IgA coating (179, 180). Class switch recombination to IgA 
occurs mainly in the mLNs and PP through both T cell-dependent 
and T cell-independent mechanisms, and studies in GF mice 
established that commensal microbiota is strong inducers of IgA 
production (178, 179, 181). In the T cell-independent pathway, 
microbiota induces production of IgA through the modulation 
of IECs and MPs, which in turn secrete BAFF (B cell-activating 
factor), APRIL (a proliferation-inducing ligand), and TGF-β1, 
cytokines that promote IgA switching (178). Production of IgA in 
response to microbiota appears very flexible, as IgA specificity can 
rapidly change and adapt in response to alterations in microbiota 
composition (182, 183).
Pentameric IgM antibodies are also actively secreted into the 
intestinal lumen via the pIgR, have a similar function in shield-
ing IECs from antigenic exposure, and are particularly important 
in newborns (177). There is also evidence that active transport 
across the epithelial layer takes place for IgG and IgE. In case of 
IgG antibodies, the neonatal Fc receptor (FcRn) is responsible for 
transcytosis across the IECs, and moreover, this transport is bidi-
rectional, as IgG are able to bind antigen in the lumen and immune 
complexes may then be retrieved and released into LP, where they 
are proposed to provide antigen for DC sampling (184, 185). 
Mucosal sites, including the intestine, support isotope switching 
to IgE and indeed IgE is relatively abundant in the intestine (186, 
187), with increased production being described in patients with 
food allergies (188, 189). IgE transcytosis across the intestinal 
epithelial barrier involves the low-affinity IgE-specific receptor 
CD23/FcRII, and, similar to IgG, also appears to be bidirectional, 
potentially resulting in antigen retrieval from the lumen to the 
intestinal LP (190–192). Active transport of IgE across the IECs 
to the lumen might have a particularly important role during 
helminth infections, as the concentration of IgE in the lumen after 
parasitic infection rapidly increases (193). However, the transport 
of antigen complexes from the lumen is thought to facilitate the 
rapid intestinal physiological changes that occur during allergic 
reactions to food antigens (187). Recent data demonstrated that 
IgE in the gut acts beyond driving immediate hypersensitivity 
reactions and mediates long-lasting immunomodulatory func-
tions by enhancing the induction of proallergic Th2 cells and 
inhibiting Treg cell induction (194).
Autophagy Regulates Plasma 
Cell Responses
In contrast to what has been described for T lymphocytes (see 
below), autophagy seems largely dispensable for the development 
and maintenance of mature B lymphocytes in the periphery. 
Studies using mice with B cell-specific deletion of Atg5 or Atg7 
(Cre expressed under the control of the CD19 promoter: Atg5ΔCD19 
or Atg7ΔCD19 mice) indicated that the numbers of mature B cells 
and the ratios of marginal-zone B cells to follicular B cells are 
not affected when autophagy is lacking (195–197). Interestingly, 
while B-2 and B-1b populations were not affected by Atg5 or Atg7 
deficiency, the B-1a B cell population in the peritoneal cavity was 
markedly reduced. It remains unclear why the development of 
this population of peripheral B-1a cells is uniquely sensitive to 
autophagy deficiency (195–197).
However, studies on antibody responses, plasma cell and 
memory B cell formation provided evidence of a role for 
autophagy in regulating these processes (Figure  3). After 
examining the capacity of autophagy-deficient B cells to produce 
immunoglobulins, Conway et  al. reported decreased primary 
antibody responses to antigen immunization or following 
infection with Heligmosomoides polygyrus, along with defective 
plasma cell differentiation (196). However, in contrast, a recent 
report observed no defects in primary antibody responses from 
autophagy-deficient B cells after antigen immunization (197). 
Moreover, an extensive analysis of autophagy-deficient plasma 
cells revealed that although autophagy did not affect differentia-
tion or proliferation of plasma cells, it was necessary to promote 
their long-term survival (195). Surprisingly, immunoglobulin 
production was, in fact, increased in Atg5-deficient plasma cells, 
a phenomenon attributed to a dysregulated ER stress pathway. 
Signs of elevated ER stress were observed in autophagy-deficient 
plasma cells, leading to increased Blimp-1 expression, which in 
turn resulted in increased IgH expression and immunoglobulin 
production (195). However, after in vivo challenge with a pneu-
mococcal vaccine, antibody levels were reduced, as a result of 
decreased survival of autophagy-deficient plasma cells (195). As 
the choice of the antigen and adjuvant for immunization had a 
significant impact on the in vivo antibody responses in Atg5ΔCD19 
mice, it is plausible that some of the discrepant observations were 
due to the different immunization regimes (195). It is noteworthy 
that a requirement for autophagy appears to be shared by distinct 
types of professional secretory cells with high protein synthesis, 
as Paneth cells, goblet cells, and plasma cells are particularly 
sensitive to perturbations in autophagy and ER stress pathways.
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Recent studies on B cell responses after influenza virus infec-
tion showed that although autophagy was dispensable for initial 
memory B cell formation, the survival of memory B cells and 
secondary antibody responses after re-challenge were heavily 
dependent on autophagy, and this defect could be partially res-
cued by treatment with a ROS scavenger (197, 198). These results 
parallel studies on memory CD8+ T cell responses during viral 
infections where autophagy was also implicated in the late stages 
of memory cell formation (199, 200).
Overall, it appears that autophagy, while largely dispensable 
for mature B lymphocyte development, is necessary to maintain 
secondary, long-lasting antibody responses. However, one study 
reported decreased numbers of B cells in the intestinal LP and PP 
in Atg5ΔCD19 mice, indicating that intestinal B cells might have a 
higher dependence on autophagy compared with other periph-
eral B cells, although this has not been further investigated (196). 
Taking into account the marked differences displayed by the 
intestinal B cell compartment and the high constitutive demand 
for local antibody production in the intestine, it would be of inter-
est to address the potential role of autophagy in homeostasis of 
mucosal B cells and plasma cells.
AUTOPHAGY ReGULATeS T CeLL 
ReSPONSeS ON SeveRAL LeveLS
Autophagy Affects Thymic Selection  
of T Cells
Generation of T cells occurs in the thymus and requires con-
tinuous trafficking of bone marrow-derived lymphoid progenitor 
cells (201). Thymic selection acts to generate T cells that have 
self-MHC restricted TCR and do not display pathological self-
reactivity. Thymocytes with the capacity of interacting with self-
peptides presented on MHC I and MHC II molecules expressed 
on thymic cortical epithelial cells (cTEC) are positively selected 
toward the CD8 and CD4 lineages, respectively, whereas thymo-
cytes that fail to proceed through positive selection die by neglect 
(202). Negative selection then ensures deletion of thymocytes 
with potentially pathogenic specificity. During negative selec-
tion, thymocytes cease TCR rearrangement and migrate to the 
medulla where they interact with peptides expressed by thymic 
medullary epithelial cells (mTEC) and thymic antigen-presenting 
cells (APCs) (203). Intermediate affinity to self-peptide–MHC 
complexes promotes survival, whereas high affinity leads to the 
removal of such self-reactive clones by induction of apoptosis 
(clonal deletion).
Interestingly, autophagy has been implicated in shaping the 
thymic repertoire. Presentation of certain self-antigens on cTEC 
was promoted by autophagy, implying a role in positive selec-
tion (204). During negative selection, it appears that autophagy 
in mTEC is dispensable for abundant antigens, as it can be 
compensated by presentation by thymic APCs, but may be more 
important when antigen is present at lower doses (205). However, 
the physiological relevance of autophagy-associated antigen 
presentation during negative selection remains controversial, 
as autoimmunity development depended on the experimental 
model used; athymic mice which received an Atg5-deficient 
thymus developed autoimmunity (204), but this was not the case 
in mice where Atg7 was selectively deleted in thymic epithelium 
using a Cre-loxP approach (206). It is worth mentioning that 
several unconventional mucosal T cell subsets, such as invariant 
natural killer T (iNKT) cells, and CD8αα intraepithelial lympho-
cytes (IELs) undergo alternative thymic selection (207), and the 
impact of autophagy in the thymic epithelium on their selection 
is yet to be investigated.
The intestinal Mucosa Has a  
Unique T Cell Composition
The intestinal LP and epithelium together contain the largest 
population of T lymphocytes in the body (208). Gut T cells 
are highly heterogeneous, and many populations are unique to 
the mucosa. T cells found at the basement membrane between 
enterocytes are classified as IELs, which are particularly abundant 
in the small intestine. Two major subtypes can be distinguished in 
mice: conventional IELs, which express CD4 or the CD8αβ het-
erodimer as well as an αβTCR, and unconventional IELs, which 
express the CD8αα homodimer and either a γδTCR or an αβTCR 
(208). Overall, γδ T cells constitute a large proportion of IELs 
(approximately 60%), while CD4+ T cells are underrepresented 
(209). Intestinal IELs not only regulate epithelial growth and 
homeostasis, for example, through secretion of TGF-β1 (209) but 
are also essential in protection against pathogens, as γδ T cells are 
an important source of IL-17A (210).
The intestinal LP harbors a significant population of CD4+ 
T  cells, which predominantly express TCRαβ. Conventional 
CD8+ T cells are also present, although in lower frequencies, and 
these give rise to effector cytotoxic T lymphocytes (CTLs) that 
combat intracellular pathogens (211–213). In addition, small 
subsets of T cells that express an invariant TCR are also present 
in the intestinal mucosa (208). These subsets include mucosal-
associated invariant T (MAIT) cells and iNKT cells. MAIT cells 
express a semi-invariant TCR that recognizes bacteria-derived 
vitamin B metabolites presented by the MHC class I-related 
protein (MR1) (214). MAIT cells contribute to protection against 
enteric bacteria, as they rapidly produce cytokines and exert 
cytolytic activity upon activation (214). iNKT cells, which in mice 
constitute approximately 0.5% of small intestinal LP lymphocytes, 
express an invariant form of the TCRαβ that is able to recognize 
lipid antigens presented by the CD1d molecule (215). As well as 
cytolytic activity, iNKT cells can also rapidly produce a spectrum 
of effector cytokines at an early stage in immune responses, 
including IFN-γ, IL-4, IL-10, IL-13, and IL-17A, allowing these 
cells to participate in a range of immune responses, including 
antimicrobial defense (215).
Commensal microbiota modulates the function of IELs 
for example, GF mice (or mice treated with antibiotics) have 
reduced numbers IL-17 producing γδ T cells (216). In addition, 
the antimicrobial response of γδ T cells can be triggered by a 
distinct subset of commensal bacteria following penetration of 
the epithelial barrier (217). The influence of commensals also 
extends to iNKT cells, as exposure to commensal microbiota 
during the neonatal period limits the accumulation of iNKT cells 
at mucosal sites, which otherwise can have detrimental effects in 
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adult animals, such as increased susceptibility to asthma (218). 
Mechanistically, the inhibition of colonic iNKT cell develop-
ment by commensal microbiota is at least in part mediated by 
the interaction of iNKT cells with commensal-derived inhibitory 
sphingolipids (219).
Naive T cells are maintained in a metabolic state that favors 
energy production over biosynthesis and rely on mitochondrial 
oxidative pathways for maximal energy generation, fueled pre-
dominantly by lipid and amino acid oxidation (220). Within the 
intestinal mucosa, the majority of the T cells display an activated/
memory phenotype (211). Activation of T cells initiates multiple 
changes in their transcriptional and translational program, which 
go hand in hand with dynamic metabolic changes, matching 
bioenergetic and biosynthetic demands. Activation of T cells 
drives a rapid proliferative response, which drastically increases 
the demand for energy and building blocks for biosynthesis (220). 
During the initial growth phase, lipid oxidation is downregulated, 
and glycolytic, pentose phosphate, and glutaminolytic pathways 
increase (221). This initial metabolic shift is orchestrated by the 
transcription factors c-Myc, hypoxia-inducible factor-1α (HIF-
1α), and the nuclear receptor estrogen-related receptor α (ERRα), 
leading to an increase in amino acids, nucleic acids, and lipid 
synthesis (222–224). Toward the end of an immune response, a 
small proportion of the T cells differentiate into memory T cells 
and revert back to lipid oxidation, maintaining increased capacity 
for efficient energy generation (224).
Memory T cells are formed from both CD4+ and CD8+ effector 
T cells, and it is now appreciated that this long-term immunity 
is provided by several distinct subsets of memory cells that can 
be distinguish, based on their location and effector functions, 
into central memory T cells, effector memory T cells, and tissue-
resident memory T cells (TRM) (225). Mucosal tissues are enriched 
in TRM; in contrast to other memory cells TRM do not re-enter the 
circulation and are retained in the mucosa where they provide a 
rapid protection during a secondary local infection (226).
T Helper Cell Populations in the Gut
Upon activation, CD4+ T cells differentiate into subsets of 
T  helper cells, which have traditionally been classified accord-
ing to the expression of the lineage-specifying transcription 
factors (so-called master transcriptional regulators) and effector 
cytokine profiles. As such, Th1, Th2, Th17, and T follicular helper 
(Tfh) effector cells can be distinguished. Metabolic signals and 
the surrounding cytokine milieu greatly affect the differentiation 
process (227). As CD4+ T cells begin to proliferate and differenti-
ate, metabolic programs support the commitment into separate 
lineages, with major roles for mTOR and AMPK in tailoring the 
metabolic adaptations of particular CD4+ T cell subsets (228, 
229). Although this paradigm provides a useful framework for 
defining different functional CD4+ T cell responses, recent data 
suggest that it oversimplifies the dynamic interactions within the 
transcriptional network that orchestrates CD4+ T cell differentia-
tion, which in turn provides a degree of functional and phenotypic 
plasticity within CD4+ T cell subsets (230, 231). Nevertheless, 
the functional specialization of CD4+ T cells generates effective 
immune responses that are tailored to meet particular infectious 
or inflammatory insults.
Th1 cells are characterized by production of the signature 
cytokine IFN-γ, but can also secrete TNF-α, GM-CSF, and 
lymphotoxin, and they are considered good producers of IL-2 
(227). T-bet (T-box expressed in T cells) is the master tran-
scription factor that orchestrates Th1 cell development (232). 
Metabolic sensors that favor differentiation toward Th1 lineage 
include signaling through mTORC1, which results in a strong 
engagement of glycolysis (220). Through the production of 
IFN-γ, Th1 cells are potent activators of macrophages and thus 
play a major role in the defense against intracellular pathogens 
such as Leishmania (233) and Toxoplasma (234, 235). However, 
aberrant Th1 responses have been implicated in several chronic 
inflammatory disorders, including type I diabetes (236), multiple 
sclerosis (237), and IBD (238).
Th2 cells are characterized by the production of IL-4, IL-5, 
IL-9, IL-13, and amphiregulin. IL-4 plays a crucial role in direct-
ing Th2 polarization (239). Other factors that promote Th2 dif-
ferentiation include the alarmins TSLP, IL-33, and IL-25, which 
are released by epithelial cells in response to tissue injury and 
prime DCs and basophils to promote Th2 responses (240, 241). 
Th2 cell lineage commitment is orchestrated by the transcription 
factor Gata3, which is induced in response to IL-4 driven activa-
tion of STAT6 (242, 243). Although mTORC1 signaling is needed 
for Th2 cell lineage specification, Th2 cells are considered to be 
more reliant on mTORC2 in comparison to other T helper subsets 
(244, 245). Th2 responses are important in promoting tissue 
repair pathways (246), defense against large helminth parasites 
(247), resistance against toxins and venoms (248), and regulation 
of glucose homeostasis, adiposity, and thermogenesis (249, 250). 
However, the host protective functions of type 2 immunity are 
mirrored by detrimental effects when their activation is persistent 
or dysregulated. As such, type 2 responses can induce fibrosis, 
promote allergic diseases, including asthma and food allergies, 
and antagonize anti-tumor defense (241).
T follicular helper cells are becoming recognized as a separated 
lineage of CD4+ T cells that specialize in the provision of help for 
B cell responses. Tfh assistance is essential to induce maturation, 
isotype switching, and terminal differentiation of B cells (251), 
events that occur mainly within germinal centers (GC). As such, 
Tfh cells are essential for the production of most types of antibod-
ies, although their role in IgE responses remains unclear (252). The 
transcriptional repressor B cell lymphoma 6 (Bcl-6) orchestrates 
Tfh lineage commitment and is both necessary and sufficient to 
drive Tfh differentiation (253–255). Not much is known about 
specific metabolic requirements of Tfh cells; however, recent 
evidence suggest that these cells have reduced mTORC1 activity 
and are less glycolytic compared with Th1 cells (256).
Th17 cells are characterized by production of the signature 
cytokines IL-17A, IL-17F, and IL-22 (257–261) and expression 
of IL-23R and the chemokine receptor CCR6 (262, 263). The 
transcription factor Rorγt is considered to be the master regulator 
of Th17 cells (264). A natural ligand for Rorγt – an intermediate 
of cholesterol biosynthesis pathway – has recently been identified 
(265, 266). The differentiation into Th17 cells requires TGF-β1 in 
the presence of proinflammatory cytokines, including IL-1β, and 
STAT3-activating cytokines, such as IL-6 or IL-21 (267), whereas 
IL-23 plays an essential role in sustaining Th17 differentiation 
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and promoting their survival and acquisition of pathogenic effec-
tor potential (268–270). Similar to Th1 cells, Th17 cells require 
mTORC1 activation during differentiation, but are additionally 
dependent on HIF-1α activity and are thought to heavily rely on 
glycolysis, as blocking glycolysis with 2-deoxy-d-glucose (2-DG) 
inhibits Th17 cell differentiation (271, 272). Recently, fatty acid 
synthesis (FAS) was also shown to dictate the balance between 
Th17 and Treg differentiation, where de novo FAS promoted 
Th17 over Treg cell differentiation (273). Th17 cells are enriched 
at mucosal sites where they play a key role in protection against 
various extracellular pathogens, including fungal and bacterial 
infections (267, 274–276). However, Th17 cells have also been 
implicated in several chronic inflammatory and autoimmune 
disorders, including intestinal inflammation (267, 268, 277) and 
neurological disorders (278).
Commensal microbiota modulates abundance and function 
of intestinal Th cells, and this is well exemplified by the effect 
on Th17 cells. GF mice show reduced frequencies of intestinal 
Th17 cells, which can be restored upon colonization with the 
segmented filamentous bacteria (SFB), Gram-positive bacteria 
belonging to the Clostridiales genus (279, 280). How SFB pro-
mote effector T cell polarization and accumulation is still not 
completely understood, but it was proposed that SFB coloniza-
tion increases levels of the acute-phase protein serum amyloid A 
(SAA), which conditioned intestinal MPs to promote Th17 cells 
(279). More recently, presentation of SFB antigens on MHC II 
molecules by intestinal DCs was implicated in SFB-specific Th17 
cells differentiation (281, 282). Of note, it remains unknown 
whether equivalent single bacteria species able to promote Th17 
cells exist in humans. Additionally, it was shown that Th17 cells 
could directly detect microbial-associated molecules through 
TLR2 and that this potentiated Th17 responses (283).
Regulatory T Cells in the  
intestinal Mucosa
In comparison to the systemic immune compartment, the intesti-
nal mucosa is significantly enriched in regulatory T cells and their 
non-redundant role in controlling intestinal inflammation is well 
documented (284, 285). The majority of these cells are Foxp3+ 
Treg cells. Foxp3 is a master transcriptional regulator of Treg cells, 
necessary for their development and maintenance (286). Treg 
cells can be generated in the thymus during development (tTreg 
cells), or in the periphery from conventional naive CD4+ T cells 
(pTreg cells). Differentiation of tTreg cells requires a transient 
TCR stimulation with a particular strength of TCR signaling 
following recognition of self-peptides, which corresponds to 
a TCR avidity between the one that dictates positive selection 
and the one that leads to negative selection (287). Induction of 
pTreg cells from naive CD4+ T cells in  vivo occurs when anti-
gen is presented under subimmunogenic or non-inflammatory 
conditions, during chronic inflammation, and in the setting of a 
tolerogenic microenvironment, which includes the intestinal LP 
(288). Indeed, the gastrointestinal tract is a preferential site of 
pTreg cell conversion; however, whether pTreg and tTreg have 
overlapping or distinct functions in maintaining gut homeostasis 
is an ongoing question (211).
The mechanisms used by Treg cells to suppress deleterious 
inflammatory responses have been extensively studied. They 
include production of regulatory cytokines (IL-10, TGF-β1, and 
IL-35), suppression by metabolic disruption, direct modulation 
of DC function, and cytolysis (289). In the context of intestinal 
homeostasis, IL-10 and TGF-β1 are of particular importance in 
enforcing tolerance and genetic deletion of IL-10, IL-10R, or 
impairment of the pathway results in microbiota driven intestinal 
inflammation in mice and humans (284, 285, 290).
Treg cells display specific adaptations that are tailored to the 
environmental context in which they operate. It was recently 
proposed that circulating Treg cells could be therefore divided 
into central, effector, and tissue-resident Treg cell popula-
tions (291). The existence of memory Treg cells has also been 
postulated (292–295). Tissue-resident Treg cells are long-term 
residents within various non-lymphoid organs, to which they 
adapt through transcriptional and metabolic reprograming (296). 
Potentially, each organ might have its own specific Treg cell popu-
lation, and tissue-resident Treg cells have been described in skin, 
muscle, adipose tissue, placenta, and the intestine (296). Gut-
resident Treg cells express chemokine receptors and adhesion 
molecules that facilitate gut homing, such as β7 family integrins 
and CCR9, expression of which is promoted by RA (121, 297), 
and G protein-coupled receptor 15 (GPR15) (298). Additionally, 
gut-resident Treg cells can be characterized by expression of the 
high affinity IL-2 receptor and the short-chain fatty acid (SCFA) 
receptor GPR43 (299). It is important to note that due to difficul-
ties in distinguishing between effector and tissue-resident Treg 
cell populations the degree of plasticity between them remains 
unclear. Overall, Treg cells are thought to metabolically resemble 
memory T cells, in that they preferentially rely on lipid instead of 
glucose metabolism for energy generation; however, it remains 
largely unexplored whether particular subpopulations of Treg 
cells are metabolically distinct (220).
Commensals influence Foxp3+ Treg cell induction in the gut in 
several ways. For instance, the capsular polysaccharide A (PSA) 
of the Gram-negative anaerobic commensal Bacteroides fragilis 
was shown to promote IL-10 producing Foxp3+ Treg cells (300) 
through direct interaction of PSA with TLR2 on T lymphocytes 
(301). Furthermore, metabolites, such as SCFA, are emerging as 
key homeostatic signals provided by commensal microbiota to 
regulate local Treg cells. SCFA, such as butyrate and acetate, can 
act directly on mucosal Treg cells to promote their expansion. 
Mechanistically, butyrate appeared to promote pTreg cell induc-
tion by inhibiting histone deacetylases (HDAC). Butyrate-treated 
naive CD4+ T cells exhibited increased acetylation of the Foxp3 
locus, including the key CNS1 enhancer region that is essential 
for pTreg differentiation (299, 302, 303). Of note, recent reports 
indicate that pTreg cells induced by the commensal microbiota 
antigens can be distinguished from other pTreg cells based on 
their expression of Rorγt (304, 305), suggesting an additional 
level of Treg cell specialization may exist in the gut.
Autophagy Regulates T Cell Survival
The first indication of the importance of the autophagy pathway 
for T lymphocyte homeostasis in vivo came from the study of 
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Atg5−/− fetal liver chimeric mice where decreased numbers of 
thymic and splenic autophagy-deficient CD4+ and CD8+ T cells 
were reported (306). Several genetic models were subsequently 
employed to investigate a specific role for autophagy in T cell 
development. These studies investigated T cells within the 
thymus and in the secondary lymphoid organs, including 
spleen and lymph nodes. T cell-specific deletion of Atg3, Atg5, 
Atg7, Atg16l1, Vps34, or Beclin1 consistently showed decreased 
frequencies and numbers of CD4+ and CD8+ T in the second-
ary lymphoid organs, whereas thymic development was largely 
unperturbed (200, 307–312). However, the requirement for 
autophagy in thymic development seems to be dependent on 
the system that was used to generate T cell-specific deletion of 
autophagy genes. While mice where Cre recombinase expres-
sion was driven by the Lck promoter (Cre expression occurs 
at the double negative stage) showed a mild, but significant, 
reduction in thymocyte numbers (308, 313), mice where the 
CD4 promoter was used to drive Cre expression (resulting in 
excision during the later double positive stage) did not show 
any significant changes in thymocyte development (200, 307, 
310, 312). One exception is NKT cells, which require autophagy 
during thymic development (309, 314, 315).
These studies also observed increased proportions of effector/
memory phenotype (CD62low CD44hi) T cells among peripheral 
autophagy-deficient T cells, which was interpreted to be a result 
of decreased survival of naive T cells (308, 311). However, this 
phenotype might also occur as a result of lymphopaenia-induced 
proliferation (200). The role of autophagy in activated T cells 
has been predominantly studied in vitro. The question of when 
autophagy is activated in T cells remains controversial. While 
autophagy is known to be negatively regulated by mTORC1 sign-
aling in many cell types, and therefore inversely correlates with 
cell proliferation (21), early in vitro studies indicated that TCR 
triggering induces autophagy in T lymphocytes and reported 
that chemical or genetic blockage of the autophagy pathway 
impaired T cell activation and proliferation (306, 308, 316, 317). 
Autophagy-deficient T cells also showed increased apoptosis 
during prolonged in vitro culture (308) or after activation (310, 
312). Some of the studies also observed decreased production 
of effector cytokines by in  vitro activated autophagy-deficient 
T cells, including IL-2, IL-17A, and IFNγ (309, 317). Conversely, 
another study reported increased IL-2 production by Atg7-
deficient CD4+ T cells after TCR cross-linking (318). In several 
studies, these defects in autophagy-deficient T cells were linked 
to impaired organelle homeostasis, particularly mitochondria 
homeostasis, and were associated with an increase in ROS 
production (307, 308, 311). Increases in ER mass and changes 
in intracellular calcium signaling were also implicated in this 
impaired fitness and survival (318). However, whether this is 
indeed the mechanistic explanation for the decreased fitness 
of autophagy-deficient CD4+ T cells in  vivo remains unclear, 
as other studies did not observe any increase in mitochondrial 
mass or ROS production (310, 319), and mitochondria were 
shown to be excluded from autophagosome degradation in 
activated wild-type CD4+ T cells (317). Further complication 
arises from the findings that although increased ROS can be 
detrimental for T cells (320), ROS production is increased after 
TCR triggering and is, in fact, required for T cell proliferation, 
particularly in CD8+ T cells (321–324). It was also proposed 
that imbalanced expression or accumulation of apoptosis-
related proteins might contribute to the defective proliferation 
and survival of autophagy-deficient T cells. However, these 
results are difficult to interpret as increased levels of both 
proapoptotic (308–310) and anti-apoptotic proteins (Bcl-2, 
Mcl-1) (308–310) have been reported in autophagy-deficient 
T cells. Analysis of mice with T cell-specific deletion of Vps34 
suggested that decreased levels of IL-7Rα expression on T cells 
might be involved, although this was not attributed to the cell-
intrinsic effects of autophagy deficiency (307, 319). Treatment 
with the pan-caspase inhibitor zVAD could partially rescue the 
apoptotic phenotype of autophagy-deficient T cells (308, 310); 
however, it did not rescue the defects in T cell proliferation 
(309). Furthermore, it is worth pointing out that in addition to 
its role in T cell survival and proliferation, autophagy has also 
been reported to promote cell death in activated T cells under 
some circumstances (316, 325, 326).
Interestingly, autophagy has been directly linked to regulation 
of signaling cascades downstream of the TCR. For example, 
in activated, but not in naive T cells, autophagy was shown to 
selectively target Bcl-10 for degradation in a p62-dependent 
manner, limiting NFκB-dependent effector responses, includ-
ing IL-2 secretion (29). NFκB signaling plays an important role 
in many aspects of activated T cell physiology, including entry 
into cell cycle (327), but the strength of NFκB signaling can also 
influence differentiation into distinct Th cell subsets; therefore, 
autophagy might contribute to these processes by regulating the 
NFκB pathway in activated T cells.
Recent reports identified a role of autophagy in the formation of 
memory CD8+ T cells during viral infections (199, 200, 328). These 
studies, which focused on in vivo responses of autophagy-deficient 
CD8+ T cells to influenza or lymphocytic choriomeningitis virus 
infections, revealed new aspects of autophagic regulation of T 
cells. Although distinct genetic approaches were used to generate 
mice with a selective autophagy deficiency in T cells, all observed 
that autophagy was dispensable during the early expansion phase 
of antigen-activated CD8+ T cells during viral infection (199, 200, 
328). In addition, autophagy-deficient T cells did not show defects 
in effector cytokine production and were capable of controlling 
virus titers during the early phases of infection (199). However, 
activation of the autophagy pathway was shown to be crucial dur-
ing the transition phase between late effector to memory T cells 
and mice with autophagy-deficient CD8+ T cells did not mount 
proper memory CD8+ T cell responses during secondary chal-
lenge (199, 200, 328). While the mechanism behind the require-
ment for autophagy in memory CD8+ T cell responses remains 
to be elucidated, comparison of metabolic profiles between WT 
and Atg7-deficient memory CD8+ T cells suggested that meta-
bolic adaptation might be involved (199). In addition, CD8+ T 
cells from aged mice (200) and senescent human CD8+ T cells 
exhibited low levels of autophagy, which in human senescent cells 
was associated with high p38 kinase activity (329). Importantly, 
increasing autophagy levels was shown to boost memory CD8+ T 
cell responses after influenza vaccination in aged mice (200). Of 
note, it remains unknown whether autophagy is equally essential 
FiGURe 5 | Defective autophagy alters the balance of the intestinal CD4+ T cell subsets. T cell-specific ablation of autophagy results in a strong decrease in 
the numbers of Treg cells and also reductions in Th1 and Th17 effector cells. Conversely, loss of autophagy promotes expansion of intestinal Th2 cells, leading to 
aberrant responses to luminal antigens and subsequent intestinal pathology. Ag - antigen.
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for the development of CD4+ T cell memory cells and whether 
autophagy plays any role in the formation of TRM cells, including 
mucosal TRM cells.
Overall, while it is clear that autophagy plays a crucial role 
in the maintenance of peripheral CD4+ and CD8+ T cells and 
memory CD8+ T cells (Figure  3), it is still not completely 
understood how autophagy influences different aspects of T cell 
physiology in naive and activated T cells. Methodological difficul-
ties of monitoring autophagy, differences in the genetic models 
used, as well as differences between in vivo and in vitro stimuli 
might underlie some of the discrepancies observed. Indeed, 
autophagy is an essential homeostatic process for all eukaryotic 
cells, including T cells. Therefore, genetic deletion of essential 
autophagy genes early during T cell development, using CD4 
or Lck promoter driven Cre-lox technology, can mediate major 
changes in autophagy-deficient T cells, including global altera-
tions in gene expression (313). Arguably, this makes it difficult to 
study the function of essential autophagy genes in isolation on a 
particular process or step of T cell development. In order to avoid 
this complication, several groups attempted to use an inducible 
system to selectively knock-out autophagy genes at a chosen time 
point (311, 328), or used the granzyme B promoter to selectively 
drive Cre expression in mature CD8+ T cells (199). However, in 
the context of intestinal homeostasis, it is important to remember 
that in terms of revealing how polymorphisms in autophagy genes 
are linked to disease susceptibility, the system where autophagy 
is perturbed from the beginning of T cell development may be 
physiologically relevant.
Autophagy Regulates the Balance 
of intestinal CD4+ T Cell Subsets
Although these studies investigated the role of several autophagy 
genes in T cell physiology, intestinal populations of T cells were 
not analyzed. We studied the role of the IBD susceptibility gene 
Atg16l1 in the intestinal T cell homeostasis and function (312). 
This study showed that autophagy pathway was essential for 
the maintenance of T cells in the small intestinal and colonic 
mucosa, as CD4+ and CD8+ T cell numbers were strongly 
reduced in the mice with selective Atg16l1-deficiency in the 
T cell compartment (312). Moreover, detailed examination of 
intestinal CD4+ T cell subsets revealed that Atg16l1-deficiency 
differentially affected distinct subsets of CD4+ T cells in the gut; 
it strongly compromised the Treg cell compartment, whereas 
the Th2 population was selectively enhanced. In addition, Th1 
and Th17 cells, which are commonly implicated in intestinal 
pathology, were reduced in the gut of mice with Atg16l1-deficient 
T cells (Figure  5). These changes were most pronounced in 
the intestinal mucosa, suggesting different requirements for 
autophagy for the accumulation and survival of distinct subsets 
of CD4+ T cells within the intestinal environment. Aged mice 
with T cell-specific deletion of Atg16l1 developed spontaneous 
and progressive intestinal pathology, which was preceded by 
the production of Th2-associated antibodies toward dietary 
and commensal antigens (312). These aberrant type 2 responses 
resulted not only from a lack of sufficient Treg control but also 
from cell-intrinsic dysregulation, as T cell-intrinsic autophagy 
limited the expansion of Th2 cells (312).
By generating mice with a Treg cell-specific deletion of 
Atg16l1, we demonstrated that cell-intrinsic autophagy is 
indispensable for Treg cell maintenance in the periphery and 
thus for the control of effector T cell responses, as these mice 
developed severe systemic and gastrointestinal inflammation. 
These findings are consistent with an independent study, 
which reported that Treg cell-specific deletion of Atg5 or Atg7 
led to the spontaneous development of severe multi-organ 
inflammation (330). Autophagy-deficient Treg cells exhibited 
marked phenotypical changes, including increased cell cycling, 
FiGURe 6 | Differential reliance on autophagy within intestinal T cell 
subsets corresponds to their different metabolic profiles. Cell-intrinsic 
defects in autophagy negatively affect T cell subsets, with the exception of 
Th2 cells. Treg cells and memory CD8+ T cells, which rely on lipid metabolism 
for survival, were shown to be the most sensitive to autophagy perturbation. 
However, the role of autophagy CD4+ memory T cells formation has not yet 
been investigated.
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production of Th effector cytokines, and reduced Foxp3 
expression, that were associated with increased activation of 
mTORC1 (312, 330). In addition, autophagy-deficient Treg cells 
showed a distinct metabolic profile, with increased glycolysis 
and reduced expression of genes involved in FAS/FAO (312, 
330). Increased glycolysis could be a more general phenomenon 
observed in autophagy-deficient T cells, as others reported a 
similar glycolytic shift in autophagy-deficient CD8+ memory T 
cells (200). Based on recent evidence that metabolic changes are 
emerging as an important part of tissue-specific reprograming 
of tissue-resident Treg cells (291, 296), we predict that these 
metabolic perturbations introduced by autophagy deficiency 
strongly affect intestinal Treg cells, which rely on fatty acid 
metabolism, similar to memory T cells (Figure  6) (312). In 
contrast, Th2 cells seem resistant to these metabolic changes, 
presumably due to their ability to cope with prolonged high 
levels of glycolysis, perhaps explaining why this particular Th 
cell subset were not negatively affected by autophagy deficiency 
(312) (Figure 6).
In summary, autophagy differentially regulates survival of 
Treg cells and Th2 cells; T cell-intrinsic autophagy might facilitate 
metabolic adaptations that are required for the survival of intesti-
nal Treg cells, while Th2 cell are resistant to metabolic perturba-
tions introduced by autophagy deficiency. As polymorphisms in 
ATG16L1 and other autophagy genes have been linked to IBD 
susceptibility, these results identify a potential novel mechanism 
that links genetic susceptibility in the autophagy pathway to 
intestinal inflammation through dysregulation of mucosal T 
cell responses. Moreover, as defective Treg and increased Th2 
responses at the mucosa are observed in food allergies and asthma, 
and since polymorphisms in the essential autophagy gene Atg5 
have been implicated in asthma susceptibility (331, 332), these 
findings might also have implications for these conditions that 
affect mucosal tissues.
CONCLUSiON AND PeRSPeCTiveS
In recent years, researchers have employed the Cre-lox sys-
tem to generate transgenic mice with conditional knock-out 
of autophagy genes to study the role of autophagy in a cell 
type-specific manner. While this is undoubtedly a powerful 
tool to look at autophagy functions in vivo, it is important to 
remember that these are rarely perfect, as few promoters show 
complete specificity for one cell type and off-target effects of 
autophagy gene deletion should be considered. Nevertheless, 
studies using distinct Cre lines, together with those using 
human cells with disease-associated autophagy mutations, have 
identified several key mechanisms through which autophagy 
can influence the functions of distinct cell populations in the 
gut (Table 1). However, some observations remain inconclusive 
and the molecular mechanisms through which autophagy 
controls such a range of functions in diverse cell types are 
not well defined (Table  1). It is important to point out that 
autophagy is a fundamental process in eukaryotic cells and 
complete inhibition or deletion of essential autophagy genes 
often results in strong perturbations in cellular physiology, 
including activation of compensatory or rescue pathways. 
Future studies may employ more refined approaches, such as 
using knock-in mice harboring disease-associated autophagy 
gene alleles.
The role of autophagy has been investigated for the main 
leukocyte subsets and we know a lot about how it regulates 
different aspects of their differentiation and function. However, 
the majority of these observations were made using leukocytes 
derived from secondary lymphoid tissues and extrapolation to 
the intestinal mucosa should be treated cautiously, as mucosal 
immune cells often display very distinct properties from their 
systemic counterparts. A good example of this is our discovery 
that enhanced Th2 responses in autophagy-deficient CD4+ T cells 
occur primarily within the intestinal mucosa. Emerging literature 
indicates that effector and memory T cell responses in tissues are 
dependent on metabolic adaptations that allow T cells to survive 
and function in environments with altered availability of nutri-
ents and growth factors. We speculate that autophagy plays a key 
role in endowing T cells with the metabolic flexibility to adapt 
these challenges. Thus, the immune manifestations of autophagy 
deficiency depend not only on the cell type considered but also 
on the tissue context.
Many important issues still remain to be addressed to give 
a more complete picture of how autophagy regulates intestinal 
immune homeostasis. These include a comprehensive analysis 
of the effects of autophagy on unique populations of innate 
leukocytes that are present in the gut, such as ILCs and IELs. 
In addition, the influence of autophagy on CD4+ T cell memory 
TABLe 1 | Consequences of autophagy deficiency in the intestine.
Cell type Genetic manipulation Phenotype/results Cautionary notes
Intestinal 
epithelium
Atg5Δvillin Decreased defense against intestinal intracellular bacteria 
(110, 111)Atg16l1Δvillin
Atg16l1HM Defects in structure and secretory functions in Paneth cells 
and goblet cells; increased susceptibility to DSS-induced 
colitis (13, 114, 115, 118)
In the mouse models, the phenotype may 
depend on the presence of norovirus infection, 
or additional perturbations in compensatory 
pathways like the ER stress pathway (12, 116)
Atg5Δvillin
Atg16l1T316A
CD patients with ATG16L1T300A
Mononuclear 
phagocytes
Atg5ΔCD11c Decreased MHC II antigen presentation on DCs (137, 148) Relevance for intestinal DC function in vivo 
remains to be establishedCD patients with ATG16L1T300A
Atg16l1T316A Decreased defense against intestinal intracellular bacteria 
(12, 148)CD patients with ATG16L1T300A
Atg16l1−/− fetal liver chimeric mice Defective inflammatory cytokine regulation: impaired 
autophagy results in increased IL-1β production (155, 156) 
and in increased susceptibility to DSS-induced colitis and 
sepsis (155, 158)
Autophagy seems to play a dual role in regulating 
some inflammatory cytokine pathways, as it 
was shown to both limit (158, 168, 169) and 
facilitate inflammasome and type I IFN pathways 
(147, 165, 167) – it remains unclear which effect 
dominates in intestinal mucosal MP
Map1lc3b−/−
CD patients with ATG16L1T300A
B cells Atg5ΔCD19
Atg7ΔCD19
Impaired survival of plasma cells and memory B cells; 
decreased secondary antibody responses after influenza 
infection (195, 197, 198)
Effects on local mucosal antibody responses not 
yet investigated
Effects of autophagy deficiency on primary 
antibody production remains unclear, as both 
decreased and increased serum antibody levels 
have been reported (195, 196)
T cells Atg5−/− fetal liver chimeric mice Decreased survival of peripheral CD4+ and CD8+ T cells, 
including intestinal lamina propria T cells (306, 308, 312)Atg7ΔLck
Atg16l1ΔCD4
Atg7ΔCD4 Defects in the formation of memory CD8+ T cells and 
secondary responses to viral infections (199, 200)
The requirements for autophagy for CD4+ 




Atg16l1ΔCD4 Compromised Treg cell number in the intestine; increased 





Δ designates promoter that is used to drive the Cre expression in the transgenic mouse strain.
CD, Crohn’s disease; DCs, dendritic cells; DSS, dextran sulfate sodium; ER, endoplasmic reticulum; Gzmb, granzyme B; HM, hypomorphic; IFN, interferon; Lck, lymphocytes protein 
tyrosine kinase; MP, mononuclear phagocytes; TRM, tissue-resident memory T cells.
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formation and development of TRM cell responses in the mucosa 
has still to be determined. An improved understanding of the 
molecular mechanisms that make Th2 cells resistant to the effects 
of autophagy deficiency is also required.
Autophagy is an attractive therapeutic target and several 
autophagy modulating compounds are already in clinical trials 
for the treatment of various disorders (333). For instance, the 
autophagy-enhancing drug carbamazepine has been shown to 
ameliorate hepatic fibrosis in the mouse model of α1-antitrypsin 
deficiency liver cirrhosis, and this drug is currently in phase II 
of clinical trials (333, 334). Additionally, an autophagy-inducing 
agent has been shown to decrease pathology in a mouse model 
of chemically induced colitis (335, 336). The challenge, however, 
is to identify agents that can specifically induce autophagy 
with minimal side effects on other cellular processes. Indeed, 
considerable effort in the field of autophagy research is currently 
focused on finding small molecules that can induce autophagy 
in a very selective manner (337, 338). Interestingly, as some 
of the dietary-derived compounds, including RA (339) and 
vitamin D (340), have been shown to enhance autophagy, it 
is tempting to speculate that the use of such natural inducers 
could prove beneficial for treatment of intestinal inflammatory 
disorders.
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